Annual Meeting of Shareholders - MILLERKNOLL INC
Good afternoon. My name is Kirk Look, Chief Financial Officer of Onclytics Biotech Inc., and I will be presiding over today's virtual meeting of stockholders. On behalf of Onclytics, I want to welcome you to our 2026 annual meeting of stockholders, which is now formally called to order. We are very pleased to have each of you in attendance at today's virtual meeting. Let me begin by introducing the directors of the company, who I believe in attendance by means of remote communication with us today are jared kelly wayne pisano deborah brown james parsons jonathan rigby angela holtham steve glover bern seisinger and pat andrews also virtually present here today is john dell walter of baker chile our independent auditors Matthew Mannick of Alston and Baird, our legal counsel, who will serve as Secretary of the Meeting, and Cheryl Neighbling of Broadridge, who'll serve as the Inspector of Elections of the meeting. Our order of business will be to introduce and act upon the matters of business described in the proxy statement for this 2026 Annual Meeting of Stockholders, collect the votes, and then receive a report from the Inspector of Electrons on the voting results. This brings us to the determination of a quorum. Our bylaws in Nevada law provide that the presence, in person or by proxy, of one-third of the shares of stock issued and outstanding on the record date constitutes a quoram. Ms. Kneebling, do we have a quorem? Yes, we do. Over one- third of the stock issued in outstanding as of the record date, September 22, 2026, are represented at the meeting. Thank you, Cheryl. We will proceed with voting on the matters described in the proxy statement to be acted upon at this meeting. All stockholders of record as of September 22, 2026 are entitled to vote at this virtual meeting. Any such stockholder who has not voted by proxy and now wants to vote, or who has previously voted by a proxy but now wants change that vote, may do so now by clicking on the voting button on the web portal, and following the instructions there. Stockholders who have sent in proxies or voted via telephone or internet and do not want to change their vote do not need to take any further action. The polls are now open for voting. There are four items of business to be voted on by the stockholders. First, the first item is the election of Jared Kelly, Vern Seisinger, Deborah Brown, James Parsons, Jonathan Rigby, Patricia Andrews, and Stephen Glover as directors to hold office until the annual meeting in 2027 or until a respective successor has been elected and qualified or until such director resigns or is removed from office. The second item is the ratification of the appointment of Baker Tilly as the company's independent registered public accounting firm for the 2026 fiscal year. The third item is an advisory vote to approve the compensation of our named executive officers. The fourth item is a advisory vote on the frequency of the advisory vote and compensation of our names executive officers Since there is no other business on today's agenda, we will proceed with the balloting on the foregoing items of business. They now declare the polls closed. I want to thank everyone for your participation. We'll now ask the Inspector of Elections to report on the preliminary voting results. Mr. Look, the preliminary results are as follows. nominees for director have been approved number two the ratification of the appointment of baker tilly as the company's independent registered public accounting firm for the 2026 fiscal year has been approved three the advisory vote on the compensation of the companies named executive officers their compensation has been and number four the advisory votes on the frequency of the advisory vote on the compensation of the company's named executive officers. A one year frequency has been approved. Thank you. Now that completes our formal business for today. The complete voting results will be contained in a Form 8K that will be filed with the SEC within four days following this meeting. The Form 8k will also be available on our website promptly after it is filed. I now declare the 2026 Annual Meeting of Stockholders adjourned. On behalf of our company, I would like to thank each of you for your attendance and your support of OnClinics Biotech, Inc. The conference is now concluded. Thank you for attending today's presentation. You may now disconnect.
- Company
- MILLERKNOLL INC
- Keywords
- MILLERKNOLL INC